| 000 | 01740 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514223110.0 | ||
| 264 | 0 | _c20050705 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a0300-0664 | ||
| 024 | 7 |
_a10.1111/j.1365-2265.2005.02245.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcCallum, Roland W | |
| 245 | 0 | 0 |
_aGrowth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cApr 2005 |
||
| 300 |
_a473-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aArteries |
| 650 | 0 | 4 |
_aBlood Flow Velocity _xdrug effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Hormone _xdeficiency |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypopituitarism _xblood |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMyography |
| 650 | 0 | 4 | _aPulse |
| 650 | 0 | 4 | _aVasodilator Agents |
| 700 | 1 | _aSainsbury, Christopher A R | |
| 700 | 1 | _aSpiers, Angela | |
| 700 | 1 | _aDominiczak, Anna F | |
| 700 | 1 | _aPetrie, John R | |
| 700 | 1 | _aSattar, Naveed | |
| 700 | 1 | _aConnell, John M C | |
| 773 | 0 |
_tClinical endocrinology _gvol. 62 _gno. 4 _gp. 473-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2265.2005.02245.x _zAvailable from publisher's website |
| 999 |
_c15477830 _d15477830 |
||